Exascale Labs Holdings Inc.

At $1.90, Exascale Labs Holdings' price is 100% below the $31,324.35 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

Intrinsiqq's calculator puts Exascale Labs Holdings' fair value at $31,324.35 a share. It grows revenue per share 5% a year for 5 years, applies an exit P/S of 4, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $23,493.26. Every input can be changed on the Intrinsic Value tab.

Exascale Labs Holdings scores 48 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 5 checks computed from SEC filings. Its best check is revenue growth at 111.3%, and its weakest is share count change at 0.0%. The Quality tab shows every check against its target.

No. Exascale Labs Holdings (XLAB) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.